launched in September 2025, is a direct-to-consumer haircare brand focusing on an at-home micro-infusion system for men and women dealing with hair thinning and receding hairlines. The brand quickly became profitable, with significant sales growth driven by Meta advertising. Starting from EUR 740 in its launch month, sales peaked at EUR 130,633 in February 2026 before stabilizing between EUR 54,000 - 59,000 monthly. Despite a dip in September 2026 due to advertising issues, October saw recovery. The core offering is a microneedle and active ingredient kit available in men's and women's versions, supplemented by an expanded product line comprising shampoos, conditioners, serums, and a small supplement line. Predominantly marketed in Italy, with additional sales in Spain and Poland, the brand caters to customers over 40 years old. The business is managed with about 2-3 hours of owner involvement daily, with an AI-assisted customer service operating every day. Marketing solely involves Meta ads, which represented about 50% of the previous year’s revenues, supplemented by a 10,000-strong Klaviyo email subscriber list. The sellers intend to move to a larger market, emphasizing U.S. potential. With a trackable financial performance showing a 21.3% net profit margin and operating without inventory overhead, the business offers growth opportunities in new markets and expanded marketing channels outside Meta. The prospective buyer will inherit a functioning brand setup, including domains, email lists, and managerial support post-sale, excluding the operational legal entity.